Literature DB >> 14573513

Dystrophin is required for the formation of stable muscle attachments in the zebrafish embryo.

David I Bassett1, Robert J Bryson-Richardson, David F Daggett, Philippe Gautier, David G Keenan, Peter D Currie.   

Abstract

A class of recessive lethal zebrafish mutations has been identified in which normal skeletal muscle differentiation is followed by a tissue-specific degeneration that is reminiscent of the human muscular dystrophies. Here, we show that one of these mutations, sapje, disrupts the zebrafish orthologue of the X-linked human Duchenne muscular dystrophy (DMD) gene. Mutations in this locus cause Duchenne or Becker muscular dystrophies in human patients and are thought to result in a dystrophic pathology through disconnecting the cytoskeleton from the extracellular matrix in skeletal muscle by reducing the level of dystrophin protein at the sarcolemma. This is thought to allow tearing of this membrane, which in turn leads to cell death. Surprisingly, we have found that the progressive muscle degeneration phenotype of sapje mutant zebrafish embryos is caused by the failure of embryonic muscle end attachments. Although a role for dystrophin in maintaining vertebrate myotendinous junctions (MTJs) has been postulated previously and MTJ structural abnormalities have been identified in the Dystrophin-deficient mdx mouse model, in vivo evidence of pathology based on muscle attachment failure has thus far been lacking. This zebrafish mutation may therefore provide a model for a novel pathological mechanism of Duchenne muscular dystrophy and other muscle diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14573513     DOI: 10.1242/dev.00799

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  104 in total

Review 1.  Tendon development and musculoskeletal assembly: emerging roles for the extracellular matrix.

Authors:  Arul Subramanian; Thomas F Schilling
Journal:  Development       Date:  2015-12-15       Impact factor: 6.868

2.  Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation.

Authors:  Anuradha Balasubramanian; Genri Kawahara; Vandana A Gupta; Anete Rozkalne; Ariane Beauvais; Louis M Kunkel; Emanuela Gussoni
Journal:  FASEB J       Date:  2014-03-31       Impact factor: 5.191

3.  The zebrafish runzel muscular dystrophy is linked to the titin gene.

Authors:  Leta S Steffen; Jeffrey R Guyon; Emily D Vogel; Melanie H Howell; Yi Zhou; Gerhard J Weber; Leonard I Zon; Louis M Kunkel
Journal:  Dev Biol       Date:  2007-06-23       Impact factor: 3.582

Review 4.  Extracellular matrix: The driving force of mammalian diseases.

Authors:  Renato V Iozzo; Maria A Gubbiotti
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

5.  The zebrafish dystrophic mutant softy maintains muscle fibre viability despite basement membrane rupture and muscle detachment.

Authors:  Arie S Jacoby; Elisabeth Busch-Nentwich; Robert J Bryson-Richardson; Thomas E Hall; Joachim Berger; Silke Berger; Carmen Sonntag; Caroline Sachs; Robert Geisler; Derek L Stemple; Peter D Currie
Journal:  Development       Date:  2009-10       Impact factor: 6.868

6.  Fluoxetine prevents dystrophic changes in a zebrafish model of Duchenne muscular dystrophy.

Authors:  Trent A Waugh; Eric Horstick; Junguk Hur; Samuel W Jackson; Ann E Davidson; Xingli Li; James J Dowling
Journal:  Hum Mol Genet       Date:  2014-04-23       Impact factor: 6.150

Review 7.  Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish.

Authors:  Louis M Kunkel; Estanislao Bachrach; Richard R Bennett; Jeffrey Guyon; Leta Steffen
Journal:  J Hum Genet       Date:  2006-04-01       Impact factor: 3.172

8.  Mutations in B3GALNT2 cause congenital muscular dystrophy and hypoglycosylation of α-dystroglycan.

Authors:  Elizabeth Stevens; Keren J Carss; Sebahattin Cirak; A Reghan Foley; Silvia Torelli; Tobias Willer; Dimira E Tambunan; Shu Yau; Lina Brodd; Caroline A Sewry; Lucy Feng; Goknur Haliloglu; Diclehan Orhan; William B Dobyns; Gregory M Enns; Melanie Manning; Amanda Krause; Mustafa A Salih; Christopher A Walsh; Matthew Hurles; Kevin P Campbell; M Chiara Manzini; Derek Stemple; Yung-Yao Lin; Francesco Muntoni
Journal:  Am J Hum Genet       Date:  2013-02-28       Impact factor: 11.025

Review 9.  Recent advances using zebrafish animal models for muscle disease drug discovery.

Authors:  Lisa Maves
Journal:  Expert Opin Drug Discov       Date:  2014-06-14       Impact factor: 6.098

Review 10.  Other model organisms for sarcomeric muscle diseases.

Authors:  John Sparrow; Simon M Hughes; Laurent Segalat
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.